RxDoctor Payments Data

Paige Russell, NP

Family · Sandpoint, IDNPI 1205314622

Payments from drug & device makers

$280in general payments, 2019–2025

Across 15 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$54
  • Lilly USA, LLC$38
  • Amgen$36
  • Novo Nordisk$35
  • Exact Sciences$34
  • Sage Therapeutics, LLC$26
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$280 in reported general payments places this provider in the 45th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$65,447
Medicare patients
272
Services billed
867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$63,626
EliquisApixaban55$45,292
JardianceEmpagliflozin25$34,074
XareltoRivaroxaban14$13,339
RybelsusSemaglutide12$11,091
Arnuity ElliptaFluticasone Furoate19$3,873
Atorvastatin Calcium324$3,568
Levothyroxine Sodium341$3,036
Gabapentin121$2,572
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen126$2,480
Losartan Potassium206$2,316
Rosuvastatin Calcium110$1,902
Albuterol Sulfate HfaAlbuterol Sulfate60$1,853
Bupropion XlBupropion Hcl52$1,765
Omeprazole119$1,728

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$35$74,71866 claims
PfizerEliquis$13$45,29255 claims
Boehringer IngelheimJardiance$54$34,07425 claims
Johnson & JohnsonXarelto$17$13,33914 claims
AbbVieSynthroid$15$1,15442 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 809 family providers in Idaho.

Other family in Sandpoint

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →